Switch to:
Also traded in: Austria, Chile, Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.41
UNH's Cash-to-Debt is ranked lower than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.15 vs. UNH: 0.41 )
Ranked among companies with meaningful Cash-to-Debt only.
UNH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.31  Med: 1.22 Max: No Debt
Current: 0.41
0.31
No Debt
Equity-to-Asset 0.35
UNH's Equity-to-Asset is ranked lower than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. UNH: 0.35 )
Ranked among companies with meaningful Equity-to-Asset only.
UNH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.09  Med: 0.39 Max: 0.81
Current: 0.35
0.09
0.81
Debt-to-Equity 0.64
UNH's Debt-to-Equity is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.59 vs. UNH: 0.64 )
Ranked among companies with meaningful Debt-to-Equity only.
UNH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.4 Max: 3.87
Current: 0.64
0
3.87
Debt-to-EBITDA 1.75
UNH's Debt-to-EBITDA is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. UNH: 1.75 )
Ranked among companies with meaningful Debt-to-EBITDA only.
UNH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.21  Med: 1.7 Max: 2.51
Current: 1.75
1.21
2.51
Interest Coverage 12.61
UNH's Interest Coverage is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.81 vs. UNH: 12.61 )
Ranked among companies with meaningful Interest Coverage only.
UNH' s Interest Coverage Range Over the Past 10 Years
Min: 7.03  Med: 13.77 Max: 16.76
Current: 12.61
7.03
16.76
Piotroski F-Score: 5
Altman Z-Score: 3.25
Beneish M-Score: -2.26
WACC vs ROIC
7.11%
21.78%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 7.65
UNH's Operating Margin % is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.49 vs. UNH: 7.65 )
Ranked among companies with meaningful Operating Margin % only.
UNH' s Operating Margin % Range Over the Past 10 Years
Min: 5.59  Med: 7.71 Max: 8.37
Current: 7.65
5.59
8.37
Net Margin % 5.71
UNH's Net Margin % is ranked higher than
70% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.87 vs. UNH: 5.71 )
Ranked among companies with meaningful Net Margin % only.
UNH' s Net Margin % Range Over the Past 10 Years
Min: 3.7  Med: 4.51 Max: 5.71
Current: 5.71
3.7
5.71
ROE % 26.01
UNH's ROE % is ranked higher than
77% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.89 vs. UNH: 26.01 )
Ranked among companies with meaningful ROE % only.
UNH' s ROE % Range Over the Past 10 Years
Min: 14.58  Med: 18.17 Max: 26.01
Current: 26.01
14.58
26.01
ROA % 8.48
UNH's ROA % is ranked higher than
64% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.25 vs. UNH: 8.48 )
Ranked among companies with meaningful ROA % only.
UNH' s ROA % Range Over the Past 10 Years
Min: 5.58  Med: 6.8 Max: 8.48
Current: 8.48
5.58
8.48
ROC (Joel Greenblatt) % 234.00
UNH's ROC (Joel Greenblatt) % is ranked higher than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 65.45 vs. UNH: 234.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
UNH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 234  Med: 244.25 Max: 362.4
Current: 234
234
362.4
3-Year Revenue Growth Rate 15.60
UNH's 3-Year Revenue Growth Rate is ranked higher than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. UNH: 15.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
UNH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -0.2  Med: 17.4 Max: 49.9
Current: 15.6
-0.2
49.9
3-Year EBITDA Growth Rate 14.10
UNH's 3-Year EBITDA Growth Rate is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.70 vs. UNH: 14.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
UNH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -58.6  Med: 20.6 Max: 406.6
Current: 14.1
-58.6
406.6
3-Year EPS without NRI Growth Rate 23.40
UNH's 3-Year EPS without NRI Growth Rate is ranked higher than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.70 vs. UNH: 23.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
UNH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 22.1 Max: 73.8
Current: 23.4
0
73.8
GuruFocus has detected 5 Warning Signs with UnitedHealth Group Inc UNH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» UNH's 30-Y Financials

Financials (Next Earnings Date: 2019-01-17 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

UNH Guru Trades in Q3 2017

Jana Partners 227,730 sh (New)
Caxton Associates 3,100 sh (New)
Steve Mandel 4,402,726 sh (+158.17%)
David Tepper 669,000 sh (+43.25%)
Jim Simons 310,500 sh (+42.56%)
John Burbank 64,094 sh (+4.14%)
Mairs and Power 528,027 sh (+0.43%)
Tom Gayner 663,000 sh (unchged)
Bernard Horn 36,968 sh (unchged)
John Hussman 25,000 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 281,146 sh (unchged)
Jeff Auxier 103,254 sh (-0.31%)
Ronald Muhlenkamp 58,699 sh (-0.55%)
NWQ Managers 1,764 sh (-2.70%)
Joel Greenblatt 35,237 sh (-3.02%)
Vanguard Health Care Fund 13,586,530 sh (-3.65%)
Dodge & Cox 9,605,624 sh (-4.61%)
Robert Olstein 27,000 sh (-6.90%)
Pioneer Investments 1,115,755 sh (-8.98%)
Barrow, Hanley, Mewhinney & Strauss 1,349,754 sh (-11.49%)
Mario Gabelli 59,248 sh (-14.25%)
Ray Dalio 4,492 sh (-16.15%)
Lee Ainslie 17,580 sh (-19.47%)
Andreas Halvorsen 2,104,322 sh (-19.68%)
Ken Fisher 6,171 sh (-19.85%)
Jeremy Grantham 2,870,197 sh (-19.98%)
Sarah Ketterer 888,509 sh (-28.10%)
Bill Nygren 1,545,000 sh (-29.61%)
Paul Tudor Jones 1,886 sh (-41.68%)
Signature Select Canadian Fund 42,450 sh (-47.30%)
Chris Davis 1,305,135 sh (-48.49%)
Steven Cohen 40,000 sh (-74.47%)
» More
Q4 2017

UNH Guru Trades in Q4 2017

First Pacific Advisors 3,800 sh (New)
Leucadia National 2,170 sh (New)
Paul Tudor Jones 23,887 sh (+1166.54%)
Steven Cohen 165,600 sh (+314.00%)
Pioneer Investments 1,919,846 sh (+72.07%)
Lee Ainslie 29,780 sh (+69.40%)
Joel Greenblatt 42,780 sh (+21.41%)
Ken Fisher 7,403 sh (+19.96%)
John Hussman 25,000 sh (unchged)
Tom Gayner 663,000 sh (unchged)
Steven Cohen 62,200 sh (unchged)
Bill Nygren 1,545,000 sh (unchged)
Bernard Horn 36,968 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 281,146 sh (unchged)
Ray Dalio Sold Out
Caxton Associates Sold Out
Jana Partners Sold Out
Jeff Auxier 102,474 sh (-0.76%)
Mairs and Power 521,174 sh (-1.30%)
Ronald Muhlenkamp 57,760 sh (-1.60%)
Dodge & Cox 9,417,622 sh (-1.96%)
Jim Simons 299,026 sh (-3.70%)
Sarah Ketterer 855,450 sh (-3.72%)
Jeremy Grantham 2,659,678 sh (-7.33%)
Vanguard Health Care Fund 12,288,085 sh (-9.56%)
David Tepper 591,589 sh (-11.57%)
Barrow, Hanley, Mewhinney & Strauss 1,159,116 sh (-14.12%)
Robert Olstein 23,000 sh (-14.81%)
Mario Gabelli 49,944 sh (-15.70%)
Steve Mandel 3,641,563 sh (-17.29%)
NWQ Managers 1,293 sh (-26.70%)
Andreas Halvorsen 1,488,844 sh (-29.25%)
John Burbank 4,105 sh (-93.60%)
Chris Davis 66,706 sh (-94.89%)
» More
Q1 2018

UNH Guru Trades in Q1 2018

Ron Baron 548 sh (New)
Julian Robertson 111,000 sh (New)
Leon Cooperman 196,300 sh (New)
Ray Dalio 5,609 sh (New)
Caxton Associates 1,149 sh (New)
Jim Simons 1,245,626 sh (+316.56%)
Robert Olstein 31,920 sh (+38.78%)
Lee Ainslie 41,300 sh (+38.68%)
David Tepper 706,589 sh (+19.44%)
Steve Mandel 4,254,415 sh (+16.83%)
First Pacific Advisors 4,400 sh (+15.79%)
Jeremy Grantham 2,765,749 sh (+3.99%)
Ronald Muhlenkamp 58,491 sh (+1.27%)
Tom Gayner 663,000 sh (unchged)
Bill Nygren 1,545,000 sh (unchged)
Bernard Horn 36,968 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 281,146 sh (unchged)
Leucadia National Sold Out
Steven Cohen Sold Out
John Burbank Sold Out
NWQ Managers 1,288 sh (-0.39%)
Barrow, Hanley, Mewhinney & Strauss 1,150,483 sh (-0.74%)
Mairs and Power 514,976 sh (-1.19%)
Vanguard Health Care Fund 11,953,085 sh (-2.73%)
Andreas Halvorsen 1,445,696 sh (-2.90%)
Pioneer Investments 1,848,205 sh (-3.73%)
Jeff Auxier 93,619 sh (-8.64%)
Joel Greenblatt 37,526 sh (-12.28%)
Chris Davis 55,035 sh (-17.50%)
Dodge & Cox 7,406,972 sh (-21.35%)
Mario Gabelli 38,404 sh (-23.11%)
Sarah Ketterer 572,752 sh (-33.05%)
Ken Fisher 4,601 sh (-37.85%)
Paul Tudor Jones 14,252 sh (-40.34%)
Signature Select Canadian Fund 21,550 sh (-49.23%)
John Hussman 10,000 sh (-60.00%)
» More
Q2 2018

UNH Guru Trades in Q2 2018

Diamond Hill Capital 855 sh (New)
Leucadia National 14,698 sh (New)
George Soros 20,700 sh (New)
Caxton Associates 3,647 sh (+217.41%)
Paul Tudor Jones 43,182 sh (+202.99%)
First Pacific Advisors 6,500 sh (+47.73%)
Ron Baron 733 sh (+33.76%)
Joel Greenblatt 46,885 sh (+24.94%)
Pioneer Investments 1,973,916 sh (+6.80%)
Tom Gayner 663,000 sh (unchged)
Ronald Muhlenkamp 58,491 sh (unchged)
Julian Robertson Sold Out
Ray Dalio Sold Out
Ken Fisher 4,566 sh (-0.76%)
Leon Cooperman 194,500 sh (-0.92%)
Barrow, Hanley, Mewhinney & Strauss 1,139,547 sh (-0.95%)
Chris Davis 54,296 sh (-1.34%)
Jeff Auxier 92,004 sh (-1.73%)
Mairs and Power 505,380 sh (-1.86%)
Dodge & Cox 7,185,453 sh (-2.99%)
Steve Mandel 4,121,415 sh (-3.13%)
NWQ Managers 1,233 sh (-4.27%)
Mario Gabelli 35,929 sh (-6.44%)
Vanguard Health Care Fund 11,132,836 sh (-6.86%)
Bill Nygren 1,345,000 sh (-12.94%)
Andreas Halvorsen 1,186,095 sh (-17.96%)
Sarah Ketterer 457,740 sh (-20.08%)
Bernard Horn 28,068 sh (-24.07%)
David Tepper 529,390 sh (-25.08%)
Lee Ainslie 30,480 sh (-26.20%)
Jeremy Grantham 1,965,421 sh (-28.94%)
Robert Olstein 20,000 sh (-37.34%)
John Hussman 5,000 sh (-50.00%)
Jim Simons 222,626 sh (-82.13%)
Eaton Vance Worldwide Health Sciences Fund 239,444 sh (-14.83%)
» More
» Details

Insider Trades

Latest Guru Trades with UNH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2018-06-30 Reduce -6.86%0.39%$217.2 - $255.98 $ 265.3010%11,132,836
Dodge & Cox 2018-06-30 Reduce -2.99%0.04%$217.2 - $255.98 $ 265.3010%7,185,453
Steve Mandel 2018-06-30 Reduce -3.13%0.14%$217.2 - $255.98 $ 265.3010%4,121,415
Bill Nygren 2018-06-30 Reduce -12.94%0.23%$217.2 - $255.98 $ 265.3010%1,345,000
Barrow, Hanley, Mewhinney & Strauss 2018-06-30 Reduce -0.95%$217.2 - $255.98 $ 265.3010%1,139,547
David Tepper 2018-06-30 Reduce -25.08%0.39%$217.2 - $255.98 $ 265.3010%529,390
Leon Cooperman 2018-06-30 Reduce -0.92%0.01%$217.2 - $255.98 $ 265.3010%194,500
Chris Davis 2018-06-30 Reduce -1.34%$217.2 - $255.98 $ 265.3010%54,296
Joel Greenblatt 2018-06-30 Add 24.94%0.03%$217.2 - $255.98 $ 265.3010%46,885
Mario Gabelli 2018-06-30 Reduce -6.44%$217.2 - $255.98 $ 265.3010%35,929
George Soros 2018-06-30 New Buy0.09%$217.2 - $255.98 $ 265.3010%20,700
Robert Olstein 2018-06-30 Reduce -37.34%0.32%$217.2 - $255.98 $ 265.3010%20,000
Leucadia National 2018-06-30 New Buy0.28%$217.2 - $255.98 $ 265.3010%14,698
Ken Fisher 2018-06-30 Reduce -0.76%$217.2 - $255.98 $ 265.3010%4,566
NWQ Managers 2018-06-30 Reduce -4.27%$217.2 - $255.98 $ 265.3010%1,233
Ron Baron 2018-06-30 Add 33.76%$217.2 - $255.98 $ 265.3010%733
Julian Robertson 2018-06-30 Sold Out 3.04%$217.2 - $255.98 $ 265.3010%0
Vanguard Health Care Fund 2018-03-31 Reduce -2.73%0.16%$212.55 - $248.47 $ 265.3016%11,953,085
Dodge & Cox 2018-03-31 Reduce -21.35%0.34%$212.55 - $248.47 $ 265.3016%7,406,972
Steve Mandel 2018-03-31 Add 16.83%0.66%$212.55 - $248.47 $ 265.3016%4,254,415
Barrow, Hanley, Mewhinney & Strauss 2018-03-31 Reduce -0.74%$212.55 - $248.47 $ 265.3016%1,150,483
David Tepper 2018-03-31 Add 19.44%0.26%$212.55 - $248.47 $ 265.3016%706,589
Leon Cooperman 2018-03-31 New Buy1.57%$212.55 - $248.47 $ 265.3016%196,300
Julian Robertson 2018-03-31 New Buy3.04%$212.55 - $248.47 $ 265.3016%111,000
Ronald Muhlenkamp 2018-03-31 Add 1.27%0.06%$212.55 - $248.47 $ 265.3016%58,491
Chris Davis 2018-03-31 Reduce -17.50%0.01%$212.55 - $248.47 $ 265.3016%55,035
Mario Gabelli 2018-03-31 Reduce -23.11%0.02%$212.55 - $248.47 $ 265.3016%38,404
Joel Greenblatt 2018-03-31 Reduce -12.28%0.02%$212.55 - $248.47 $ 265.3016%37,526
Robert Olstein 2018-03-31 Add 38.78%0.24%$212.55 - $248.47 $ 265.3016%31,920
Ken Fisher 2018-03-31 Reduce -37.85%$212.55 - $248.47 $ 265.3016%4,601
NWQ Managers 2018-03-31 Reduce -0.39%$212.55 - $248.47 $ 265.3016%1,288
Ron Baron 2018-03-31 New Buy$212.55 - $248.47 $ 265.3016%548
Leucadia National 2018-03-31 Sold Out 0.04%$212.55 - $248.47 $ 265.3016%0
Vanguard Health Care Fund 2017-12-31 Reduce -9.56%0.55%$192.52 - $226.78 $ 265.3025%12,288,085
Dodge & Cox 2017-12-31 Reduce -1.96%0.03%$192.52 - $226.78 $ 265.3025%9,417,622
Steve Mandel 2017-12-31 Reduce -17.29%0.72%$192.52 - $226.78 $ 265.3025%3,641,563
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -14.12%0.06%$192.52 - $226.78 $ 265.3025%1,159,116
David Tepper 2017-12-31 Reduce -11.57%0.21%$192.52 - $226.78 $ 265.3025%591,589
Chris Davis 2017-12-31 Reduce -94.89%1.03%$192.52 - $226.78 $ 265.3025%66,706
Ronald Muhlenkamp 2017-12-31 Reduce -1.60%0.06%$192.52 - $226.78 $ 265.3025%57,760
Mario Gabelli 2017-12-31 Reduce -15.70%0.01%$192.52 - $226.78 $ 265.3025%49,944
Joel Greenblatt 2017-12-31 Add 21.41%0.02%$192.52 - $226.78 $ 265.3025%42,780
Robert Olstein 2017-12-31 Reduce -14.81%0.1%$192.52 - $226.78 $ 265.3025%23,000
Ken Fisher 2017-12-31 Add 19.96%$192.52 - $226.78 $ 265.3025%7,403
Leucadia National 2017-12-31 New Buy0.04%$192.52 - $226.78 $ 265.3025%2,170
NWQ Managers 2017-12-31 Reduce -26.70%$192.52 - $226.78 $ 265.3025%1,293
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:CVS, NYSE:ANTM, NYSE:AET, NAS:ESRX, NYSE:CI, NYSE:HUM, NYSE:CNC, NYSE:WCG, NYSE:MOH, BSP:ODPV3, BSP:QUAL3, NAS:MGLN, XPAR:GDS, NAS:HIIQ, OSTO:MCOV B, ROCO:6665, ATH:IATR, ASX:ONT, TSXV:NAC, MIL:HI » details
Traded in other countries:UNH.Austria, UNH.Chile, UNH.Germany, UNH.Mexico, UNH.Switzerland, 0R0O.UK,
Headquarter Location:USA
UnitedHealth Group Inc is a diversified health care company in the United States. It designs products, provides services and applies technologies that improve access to health and well-being services, and make health care more affordable.

With about 50 million covered lives and 1.2 billion annually processed prescription claims, UnitedHealth is one of the largest MCOs and PBMs in the United States. The firm provides health insurance services to its members through products for every major insurance market--individual, group, and government sponsored. The firm also provides back-office services to providers through its Optum segment. UnitedHealth has a large nationwide operation and competes in most major U.S. geographies.

Guru Investment Theses on UnitedHealth Group Inc

Jeff Auxier Comments on UnitedHealth Group - Aug 08, 2018

UnitedHealth Group (NYSE:UNH)

Revenues for the quarter grew 13.3% to $55.2 billion. Earnings from operations increased 18.8% to $4.1 billion. Every business segment reported double-digit earnings growth. Cash flows from operations for the quarter were $8.37 billion, up 29.63%. UnitedHealth repurchased 11.6 million shares for $2.65 billion during the first quarter. They also paid $722 million in dividends, an increase of 21.1%. UnitedHealth ended its exclusivity deal with Lab Corp this quarter and added Quest Diagnostics as one of its diagnostic service providers. This will provide their customers with more diverse diagnostic options in the future.



From Jeff Auxier (Trades, Portfolio)'s second quarter 2018 shareholder letter.

Check out Jeff Auxier latest stock trades

Bernard Horn Comments on UnitedHealth Group - Jul 23, 2018

Elsewhere in health care, UnitedHealth Group (NYSE:UNH) reported solid revenues and earnings -per-share for the quarter and increased full year 2018 guidance. The company benefitted from health insurance tax reform, greater per member revenues in Medicare Advantage, strong OptumRx sales and the Empresas Banmedica acquisition in Brazil.



From Bernard Horn (Trades, Portfolio)'s Polaris Global Value Fund 2nd quarter 2018 shareholder letter.



Check out Bernard Horn latest stock trades

Jeff Auxier Comments on UnitedHealth - Feb 06, 2018

UnitedHealth (NYSE:UNH)’s data and technology platform, Optum, had another quarter and now full year of double-digit percentage earnings growth in all of its segments. Due to positive results, UnitedHealth raised their 2018 adjusted earnings guidance by 16% at the midpoint to $12.45 per share. CEO David Wichmann expects Corporate Tax Reform to boost earnings and cash flows by $1.7B in 2018.





From Jeff Auxier (Trades, Portfolio)'s fourth quarter 2018 shareholder letter.

Check out Jeff Auxier latest stock trades

GAMCO Growth Fund Comments on UnitedHealth Group - Nov 14, 2017

UnitedHealth Group (NYSE:UNH) (4.3%) (UNH – $195.85 – NYSE) is one of the largest and most diversified managed care companies in the United States. Its high growth Optum services business provides wellness and care management programs, financial services, information technology solutions and pharmacy benefit management (PBM) services to an additional 115 million customers.



From GAMCO Growth Fund third quarter 2017 commentary.



Check out Mario Gabelli latest stock trades

Jeff Auxier Comments on UnitedHealth - Aug 03, 2017

UnitedHealth (NYSE:UNH) has continued to execute since our original purchase of $46. The stock today is over $185. The company, through the heavy use of data analytics, has dominated a relatively dull industry. United’s market capitalization has continued to grow double digits every year for the last decade. The dividend was recently increased 20% to $0.75.


From Jeff Auxier (Trades, Portfolio)'s second-quarter 2017 shareholder letter.

Check out Jeff Auxier latest stock trades

Bernard Horn Comments on UnitedHealth Group Inc. - Jan 24, 2017

Three of the five largest U.S. health insurers, including UnitedHealth Group Inc. (NYSE:UNH), have pulled out of some Affordable Care Act (ACA) state exchanges. UnitedHealth Group, which lost $850 million on the state exchanges in 2016, made the decision to exit much of this business to reduce losses. Anthem echoed similar resolve. Both companies had double-digit gains, due partially to the ACA decisions as well as other initiatives. UnitedHealth announced a new drug distribution partnership with CVS. Anthem’s prospects for the Cigna merger, previously opposed by the Department of Justice, looked more favorable under the new administration.





From the Polaris Global Value Fund 4th Quarter 2016 Commentary.



Check out Bernard Horn latest stock trades

Top Ranked Articles about UnitedHealth Group Inc

Woman’s Hospital and United Health Foundation Launch Program to Help Expectant Mothers with Opioid Use Disorder
Jeff Auxier Comments on UnitedHealth Group Guru stock highlight
UnitedHealth Group (NYSE:UNH) Read more...
Lyfebulb and UnitedHealth Group Announce Winners of the 2018 Innovation Challenge for Patient Entrepreneurs
Bernard Horn Comments on UnitedHealth Group Guru stock highlight
Elsewhere in health care, UnitedHealth Group (NYSE:UNH) reported solid revenues and earnings -per-share for the quarter and increased full year 2018 guidance. The company benefitted from health insurance tax reform, greater per member revenues in Medicare Advantage, strong OptumRx sales and the Empresas Banmedica acquisition in Brazil.
Read more...
US Market Indexes Mostly Higher, Technology Falls S&P 500 gains 0.22% to close at 2,815.62
The Dow Jones Industrial Average closed at 25,199.29 on Wednesday with a gain of 79.40 points or 0.32%. The S&P 500 closed at 2,815.62 for a gain of 6.07 points or 0.22%. The Nasdaq Composite closed at 7,854.44 for a loss of -0.67 points or -0.01%. The VIX Volatility Index was lower at 12.05 for a loss of -0.01 points or -0.08%. Read more...
Lyfebulb and UnitedHealth Group Announce 11 Finalists for Their 2018 Innovation Challenge for Patient Entrepreneurs
Market Trends Toward New Normal in Cheniere Energy Partners, LP, UnitedHealth Group, Anthem, Sage Therapeutics, Harris, and A-Mark Precious Metals — Emerging Consolidated Expectations, Analyst Ratings
Dow Jones Reports 8th Consecutive Positive Close US market indexes begin the week with gains
U.S. market indexes closed higher on Monday. The Dow Jones Industrial Average closed at 24899.41 for a gain of 68.24 points or 0.27%. The S&P 500 closed at 2730.13 for a gain of 2.41 points or 0.09%. The Nasdaq Composite closed at 7411.32 for a gain of 8.43 points or 0.11%. The VIX Volatility Index closed at 12.93 with a gain of 0.28 points or 2.21%. Read more...
Lyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel Disease
US Market Indexes Close Higher Again on Tuesday Dow Jones closes at 24,786.63
U.S. market indexes were higher on Tuesday. The Dow Jones Industrial Average closed at 24,786.63 for a gain of 213.59 points or 0.87%. The S&P 500 closed at 2,706.39 for a gain of 28.55 points or 1.07%. The Nasdaq Composite closed at 7,281.10 for a gain of 124.81 points or 1.74%. The VIX Volatility Index was lower at 15.30 for a loss of -1.26 points or -7.61%. Read more...

Ratios

vs
industry
vs
history
PE Ratio 22.07
UNH's PE Ratio is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. UNH: 22.07 )
Ranked among companies with meaningful PE Ratio only.
UNH' s PE Ratio Range Over the Past 10 Years
Min: 6.31  Med: 12.99 Max: 28.31
Current: 22.07
6.31
28.31
Forward PE Ratio 18.35
UNH's Forward PE Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.27 vs. UNH: 18.35 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 22.07
UNH's PE Ratio without NRI is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. UNH: 22.07 )
Ranked among companies with meaningful PE Ratio without NRI only.
UNH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 6.31  Med: 12.99 Max: 28.31
Current: 22.07
6.31
28.31
Price-to-Owner-Earnings 31.49
UNH's Price-to-Owner-Earnings is ranked lower than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.47 vs. UNH: 31.49 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
UNH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.11  Med: 13.36 Max: 31.96
Current: 31.49
5.11
31.96
PB Ratio 4.85
UNH's PB Ratio is ranked lower than
73% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.42 vs. UNH: 4.85 )
Ranked among companies with meaningful PB Ratio only.
UNH' s PB Ratio Range Over the Past 10 Years
Min: 1  Med: 2.22 Max: 5.35
Current: 4.85
1
5.35
PS Ratio 1.18
UNH's PS Ratio is ranked lower than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.73 vs. UNH: 1.18 )
Ranked among companies with meaningful PS Ratio only.
UNH' s PS Ratio Range Over the Past 10 Years
Min: 0.27  Med: 0.61 Max: 1.24
Current: 1.18
0.27
1.24
Price-to-Free-Cash-Flow 30.29
UNH's Price-to-Free-Cash-Flow is ranked lower than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.78 vs. UNH: 30.29 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
UNH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.04  Med: 13.59 Max: 30.73
Current: 30.29
5.04
30.73
Price-to-Operating-Cash-Flow 24.26
UNH's Price-to-Operating-Cash-Flow is ranked lower than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.15 vs. UNH: 24.26 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
UNH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.31  Med: 11.32 Max: 24.61
Current: 24.26
4.31
24.61
EV-to-EBIT 16.43
UNH's EV-to-EBIT is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.89 vs. UNH: 16.43 )
Ranked among companies with meaningful EV-to-EBIT only.
UNH' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.4  Med: 8.2 Max: 17.4
Current: 16.43
4.4
17.4
EV-to-EBITDA 14.41
UNH's EV-to-EBITDA is ranked lower than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.81 vs. UNH: 14.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
UNH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.9  Med: 7.3 Max: 15.2
Current: 14.41
3.9
15.2
EV-to-Revenue 1.26
UNH's EV-to-Revenue is ranked lower than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. UNH: 1.26 )
Ranked among companies with meaningful EV-to-Revenue only.
UNH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.7 Max: 1.3
Current: 1.26
0.3
1.3
PEG Ratio 2.31
UNH's PEG Ratio is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.35 vs. UNH: 2.31 )
Ranked among companies with meaningful PEG Ratio only.
UNH' s PEG Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.22 Max: 6.11
Current: 2.31
0.7
6.11
Shiller PE Ratio 41.41
UNH's Shiller PE Ratio is ranked lower than
77% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.53 vs. UNH: 41.41 )
Ranked among companies with meaningful Shiller PE Ratio only.
UNH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.32  Med: 19.11 Max: 42.62
Current: 41.41
9.32
42.62
Current Ratio 0.69
UNH's Current Ratio is ranked lower than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.35 vs. UNH: 0.69 )
Ranked among companies with meaningful Current Ratio only.
UNH' s Current Ratio Range Over the Past 10 Years
Min: 0.57  Med: 0.77 Max: 8.45
Current: 0.69
0.57
8.45
Quick Ratio 0.69
UNH's Quick Ratio is ranked lower than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.35 vs. UNH: 0.69 )
Ranked among companies with meaningful Quick Ratio only.
UNH' s Quick Ratio Range Over the Past 10 Years
Min: 0.57  Med: 0.77 Max: 8.45
Current: 0.69
0.57
8.45
Days Sales Outstanding 18.25
UNH's Days Sales Outstanding is ranked higher than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 30.58 vs. UNH: 18.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
UNH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.99  Med: 9.02 Max: 17.36
Current: 18.25
7.99
17.36
Days Payable 43.25
UNH's Days Payable is ranked higher than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 42.32 vs. UNH: 43.25 )
Ranked among companies with meaningful Days Payable only.
UNH' s Days Payable Range Over the Past 10 Years
Min: 42.29  Med: 46.14 Max: 51.14
Current: 43.25
42.29
51.14

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.24
UNH's Dividend Yield % is ranked higher than
55% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. UNH: 1.24 )
Ranked among companies with meaningful Dividend Yield % only.
UNH' s Dividend Yield % Range Over the Past 10 Years
Min: 0.05  Med: 1.27 Max: 1.72
Current: 1.24
0.05
1.72
Dividend Payout Ratio 0.26
UNH's Dividend Payout Ratio is ranked higher than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.27 vs. UNH: 0.26 )
Ranked among companies with meaningful Dividend Payout Ratio only.
UNH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.17 Max: 0.33
Current: 0.26
0.01
0.33
3-Year Dividend Growth Rate 27.00
UNH's 3-Year Dividend Growth Rate is ranked higher than
87% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.40 vs. UNH: 27.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
UNH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 26 Max: 198.8
Current: 27
0
198.8
Forward Dividend Yield % 1.36
UNH's Forward Dividend Yield % is ranked higher than
50% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.33 vs. UNH: 1.36 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.61
UNH's 5-Year Yield-on-Cost % is ranked higher than
66% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.89 vs. UNH: 4.61 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
UNH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.18  Med: 4.68 Max: 6.34
Current: 4.61
0.18
6.34
3-Year Average Share Buyback Ratio -0.50
UNH's 3-Year Average Share Buyback Ratio is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.50 vs. UNH: -0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UNH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -24.9  Med: 1.2 Max: 6
Current: -0.5
-24.9
6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 4.85
UNH's Price-to-Tangible-Book is ranked lower than
99.99% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.76 vs. UNH: 4.85 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
UNH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.74  Med: 8.36 Max: 1392.86
Current: 4.85
2.74
1392.86
Price-to-Intrinsic-Value-Projected-FCF 1.47
UNH's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
73% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.08 vs. UNH: 1.47 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
UNH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.33  Med: 1.17 Max: 3.82
Current: 1.47
0.33
3.82
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.29
UNH's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
56% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. UNH: 1.29 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
UNH' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.31  Med: 1.5 Max: 2.62
Current: 1.29
0.31
2.62
Price-to-Median-PS-Value 1.93
UNH's Price-to-Median-PS-Value is ranked lower than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. UNH: 1.93 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UNH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.27  Med: 1.44 Max: 4.48
Current: 1.93
0.27
4.48
Price-to-Peter-Lynch-Fair-Value 2.03
UNH's Price-to-Peter-Lynch-Fair-Value is ranked lower than
73% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.09 vs. UNH: 2.03 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
UNH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.36  Med: 1 Max: 2.08
Current: 2.03
0.36
2.08
Price-to-Graham-Number 2.45
UNH's Price-to-Graham-Number is ranked lower than
99.99% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.60 vs. UNH: 2.45 )
Ranked among companies with meaningful Price-to-Graham-Number only.
UNH' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.36  Med: 3.38 Max: 37.62
Current: 2.45
1.36
37.62
Earnings Yield (Greenblatt) % 6.09
UNH's Earnings Yield (Greenblatt) % is ranked higher than
54% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.22 vs. UNH: 6.09 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UNH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.8  Med: 12.15 Max: 22.6
Current: 6.09
5.8
22.6
Forward Rate of Return (Yacktman) % 17.34
UNH's Forward Rate of Return (Yacktman) % is ranked higher than
50% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.01 vs. UNH: 17.34 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
UNH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -7.7  Med: 17.1 Max: 24.4
Current: 17.34
-7.7
24.4

More Statistics

Revenue (TTM) (Mil) $219,891.00
EPS (TTM) $ 12.02
Beta0.75
Volatility18.49%
52-Week Range $202.70 - 272.81
Shares Outstanding (Mil)962.47

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 225,137 238,962 252,421
EBIT (Mil $) 17,269 19,640 21,274
EBITDA (Mil $) 19,295 20,932 23,710
EPS ($) 12.05 13.65 15.36
EPS without NRI ($) 12.05 13.65 15.36
EPS Growth Rate
(Future 3Y To 5Y Estimate)
13.75%
Dividends per Share ($) 3.24 3.39 3.60

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}